| Siglec15 shapes a non-inflamed tumor microenvironment and predicts the molecular subtype in bladder cancer J Hu, A Yu, B Othmane, D Qiu, H Li, C Li, P Liu, W Ren, M Chen, G Gong, ... Theranostics 11 (7), 3089, 2021 | 267 | 2021 |
| A cascade nanozyme with amplified sonodynamic therapeutic effects through comodulation of hypoxia and immunosuppression against cancer N Tao, H Li, L Deng, S Zhao, J Ouyang, M Wen, W Chen, K Zeng, C Wei, ... ACS nano 16 (1), 485-501, 2021 | 130 | 2021 |
| YTHDF1 is a potential pan-cancer biomarker for prognosis and immunotherapy J Hu, D Qiu, A Yu, J Hu, H Deng, H Li, Z Yi, J Chen, X Zu Frontiers in oncology 11, 607224, 2021 | 92 | 2021 |
| Neoadjuvant immunotherapy, chemotherapy, and combination therapy in muscle-invasive bladder cancer: A multi-center real-world retrospective study J Hu, J Chen, Z Ou, H Chen, Z Liu, M Chen, R Zhang, A Yu, R Cao, ... Cell Reports Medicine 3 (11), 2022 | 73 | 2022 |
| 5mC regulator-mediated molecular subtypes depict the hallmarks of the tumor microenvironment and guide precision medicine in bladder cancer J Hu, B Othmane, A Yu, H Li, Z Cai, X Chen, W Ren, J Chen, X Zu BMC medicine 19, 1-20, 2021 | 62 | 2021 |
| LncRNA-MALAT1 mediates cisplatin resistance via miR-101-3p/VEGF-C pathway in bladder cancer P Liu, X Li, Y Cui, J Chen, C Li, Q Li, H Li, X Zhang, X Zu Acta biochimica et biophysica Sinica 51 (11), 1148-1157, 2019 | 53 | 2019 |
| High expression of long noncoding RNA NORAD indicates a poor prognosis and promotes clinical progression and metastasis in bladder cancer Q Li, C Li, J Chen, P Liu, Y Cui, X Zhou, H Li, X Zu Urologic Oncology: Seminars and Original Investigations 36 (6), 310. e15-310 …, 2018 | 53 | 2018 |
| m6A-induced lncDBET promotes the malignant progression of bladder cancer through FABP5-mediated lipid metabolism P Liu, B Fan, B Othmane, J Hu, H Li, Y Cui, Z Ou, J Chen, X Zu Theranostics 12 (14), 6291, 2022 | 41 | 2022 |
| BCAT2 Shapes a Noninflamed Tumor Microenvironment and Induces Resistance to Anti‐PD‐1/PD‐L1 Immunotherapy by Negatively Regulating Proinflammatory Chemokines and Anticancer … Z Cai, J Chen, Z Yu, H Li, Z Liu, D Deng, J Liu, C Chen, C Zhang, Z Ou, ... Advanced Science 10 (8), 2207155, 2023 | 39 | 2023 |
| Tamsulosin as a medical expulsive therapy for ureteral stones: a systematic review and meta-analysis of randomized controlled trials Y Cui, J Chen, F Zeng, P Liu, J Hu, H Li, C Li, X Cheng, M Chen, Y Li, Y Li, ... Journal of Urology 201 (5), 950-955, 2019 | 39 | 2019 |
| S100A5 Attenuates Efficiency of Anti‐PD‐L1/PD‐1 Immunotherapy by Inhibiting CD8+ T Cell‐Mediated Anti‐Cancer Immunity in Bladder Carcinoma H Li, J Chen, Z Li, M Chen, Z Ou, M Mo, R Wang, S Tong, P Liu, Z Cai, ... Advanced Science 10 (25), 2300110, 2023 | 35 | 2023 |
| Microarray expression profiles analysis revealed lncRNA OXCT1‐AS1 promoted bladder cancer cell aggressiveness via miR‐455‐5p/JAK1 signaling JB Chen, YW Zhu, X Guo, C Yu, PH Liu, C Li, J Hu, HH Li, LF Liu, ... Journal of cellular physiology 234 (8), 13592-13601, 2019 | 34 | 2019 |
| RNA modification of N6-methyladenosine predicts immune phenotypes and therapeutic opportunities in kidney renal clear cell carcinoma H Li, J Hu, A Yu, B Othmane, T Guo, J Liu, C Cheng, J Chen, X Zu Frontiers in Oncology 11, 642159, 2021 | 32 | 2021 |
| Comparison of clinical feasibility and oncological outcomes between video endoscopic and open inguinal lymphadenectomy for penile cancer: A systematic review and meta-analysis J Hu, H Li, Y Cui, P Liu, X Zhou, L Liu, H Chen, J Chen, X Zu Medicine 98 (22), e15862, 2019 | 32 | 2019 |
| Cuproptosis-related modification patterns depict the tumor microenvironment, precision immunotherapy, and prognosis of kidney renal clear cell carcinoma Z Cai, Y He, Z Yu, J Hu, Z Xiao, X Zu, Z Li, H Li Frontiers in Immunology 13, 933241, 2022 | 28 | 2022 |
| N6-Methyladenosine in Cancer Immunotherapy: An Undervalued Therapeutic Target C Quan, O Belaydi, J Hu, H Li, A Yu, P Liu, Z Yi, D Qiu, W Ren, H Ma, ... Frontiers in Immunology 12, 697026, 2021 | 21 | 2021 |
| TNF family–based signature predicts prognosis, tumor microenvironment, and molecular subtypes in bladder carcinoma H Li, S Liu, C Li, Z Xiao, J Hu, C Zhao Frontiers in Cell and Developmental Biology 9, 800967, 2022 | 19 | 2022 |
| Primary mucinous adenocarcinoma of the renal pelvis misdiagnosed as calculous pyonephrosis: a case report and literature review H Li, F Xie, C Zhao, Z Yi, J Chen, X Zu Translational andrology and urology 9 (2), 781, 2020 | 19 | 2020 |
| N6-Methyladenosine writer gene ZC3H13 predicts immune phenotype and therapeutic opportunities in kidney renal clear cell carcinoma T Guo, H Duan, J Chen, J Liu, B Othmane, J Hu, H Li, X Zu Frontiers in Oncology 11, 718644, 2021 | 18 | 2021 |
| Emerging biomarkers for predicting bladder cancer lymph node metastasis C Zhang, J Hu, H Li, H Ma, B Othmane, W Ren, Z Yi, D Qiu, Z Ou, J Chen, ... Frontiers in oncology 11, 648968, 2021 | 17 | 2021 |
